O. Usmani (London, United Kingdom), A. Yorgancioglu (Konak, Turkey)
Including the ALERT sessions (Abstracts Leading to Evolution in
Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial
A. Yousuf (Leicester, United Kingdom), S. Mohammed (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), M. Yavari Ramsheh (Leicester, United Kingdom), K. Haldar (Leicester, United Kingdom), A. Wright (Leicester, United Kingdom), P. Novotny (Leicester, United Kingdom), S. Parker (Leicester, United Kingdom), S. Glover (Leicester, United Kingdom), J. Finch (Leicester, United Kingdom), K. Hadley (Leicester, United Kingdom), N. Quann (Leicester, United Kingdom), C. Micieli (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), C. Brookes (Leicester, United Kingdom), R. Hobson (Leicester, United Kingdom), W. Ibrahim (Leicester, United Kingdom), R. Russell (Leicester, United Kingdom), D. Choy (San Francisco, United States of America), D. Cheung (San Francisco, United States of America), M. Grimbaldeston (San Francisco, United States of America), C. John (Leicester, United Kingdom), M. Steiner (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom)
|    |
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
L. Conejero Hall (Madrid, Spain), L. Puente Maestu (Madrid, Spain), M. Calle Rubio (Madrid, Spain), W. Girón (Madrid, Spain), C. Alvarez Martínez (Madrid, Spain), M. Buendía García (Madrid, Spain), J. Serra Batllés (Barcelona, Spain), J. Rodríguez Hermosa (Madrid, Spain), S. Alonso Viteri (Madrid, Spain), J. García De Pedro (Madrid, Spain), P. Benedetti (Madrid, Spain), J. De Miguel Díez (Madrid, Spain), J. Alvarez-Sala Walther (Madrid, Spain), J. Hernández Vázquez (Madrid, Spain), F. García Río (Madrid, Spain), C. Rodríguez Sainz (Madrid, Spain), C. Fernández Pérez (La Coruña, Spain), A. Doyle (Madrid, Spain), R. Caballero (Madrid, Spain), J. Subiza (Madrid, Spain), M. Casanovas (Madrid, Spain), E. Fernández-Cruz (Madrid, Spain)
| |
The relationship between eosinophils and reduction in major adverse cardiac events in ETHOS
M. Bafadhel (Oxford, United Kingdom), K. Rabe (Grosshansdorf, Germany), D. Singh (Manchester, United Kingdom), M. Jenkins (Cambridge, United Kingdom), P. Dorinsky (Durham, NC, United States of America), M. Patel (Cambridge, United Kingdom)
| |
Wrap-up by discussant and discussion
G. Brusselle (Ghent, Belgium)
| |
Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
S. Andreas (Giessen, Germany), M. Testa (Siena, Italy), L. Boyer (Paris, France), G. Brusselle (Ghent, Belgium), W. Janssens (Leuven, Belgium), E. Kerwin (Medford, OR, United States of America), A. Papi (Ferrara, Italy), B. Pek (Québec, Canada), L. Puente-Maestu (Madrid, Spain), D. Saralaya (Bradford, United Kingdom), H. Watz (Grosshansdorf, Germany), T. Wilkinson (Southampton, United Kingdom), D. Casula (Siena, Italy), G. Di Maro (Siena, Italy), M. Lattanzi (Siena, Italy), L. Moraschini (Siena, Italy), S. Schoonbroodt (Rixensart, Belgium), A. Tasciotti (Siena, Italy), A. Arora (Siena, Italy), F. Maltais (Québec, Canada)
| |
RCT Abstract - Tailored psychological intervention for anxiety/depression in people with COPD (TANDEM): a randomised controlled trial.
S. Taylor (London, United Kingdom), H. Pinnock (Edinburgh, United Kingdom), R. Sohanpal (London, United Kingdom), E. Steed (London, United Kingdom), C. Chan (London, United Kingdom), A. Healey (London, United Kingdom), R. Hooper (London, United Kingdom), K. Heslop (Newcastle upon Tyne, United Kingdom), M. Kelly (London, United Kingdom), S. Priebe (London, United Kingdom), C. Roberts (London, United Kingdom), S. Singh (Leicester, United Kingdom), S. Saqi-Waseem (London, United Kingdom), M. Underwood (Warwick, United Kingdom), P. White (London, United Kingdom), C. Warburton (London, United Kingdom)
| |
Wrap-up by discussant and discussion
J. Wedzicha (London, United Kingdom)
| |